论文部分内容阅读
目的探究二氯化锶联合唑来膦酸对激素依赖型乳腺癌转移性骨肿瘤患者缓解骨痛及生活质量的影响。方法62例激素依赖型乳腺癌转移性骨肿瘤患者,按治疗方案不同分组,各31例。对照组以二氯化锶治疗,观察组在对照组基础上联合唑来膦酸治疗,随访3个月,对比两组病灶疗效、骨痛缓解情况以及生活质量评分(GQOLI-74)。结果观察组病灶治疗总有效率54.84%(17/31)高于对照组32.26%(10/31),但无差异(P>0.05);骨痛缓解率64.52%(20/31)高于对照组38.71%(12/31)(P<0.05);躯体功能、物质生活状态、心理功能、社会功能评分均高于对照组(P<0.05)。结论二氯化锶联合唑来膦酸疗法能有效保护骨质,缓解骨痛症状,改善生活质量。
Objective To investigate the effect of strontium dichloride combined with zoledronic acid on pain relief and quality of life in hormone-dependent breast cancer patients with metastatic bone cancer. Methods 62 cases of hormone-dependent breast cancer patients with metastatic bone tumors, according to different treatment groups, 31 cases in each group. The control group was treated with strontium chloride. The observation group was treated with zoledronic acid on the basis of the control group. The follow-up period was 3 months. The curative effect, pain relief and quality of life scores (GQOLI-74) of the two groups were compared. Results The total effective rate of observation group was 54.84% (17/31), which was higher than that of control group (32.26%, 10/31), but no difference (P> 0.05). The pain relief rate was 64.52% (20/31) Group (38.71%) (12/31) (P <0.05); body function, material life status, mental function and social function scores were higher than those of the control group (P <0.05). Conclusion Strontium chloride combined with zoledronic acid therapy can effectively protect the bone, relieve the symptoms of bone pain and improve the quality of life.